Evans M H
Br J Pharmacol. 1985 Mar;84(3):645-52. doi: 10.1111/j.1476-5381.1985.tb16145.x.
Bradycardia was evoked in rabbits anaesthetized with chloralose-urethane by electrical stimulation (200 or 300 microA, 1 ms, 60 s-1 for 9 s, repeated every 5 min) of a selected point in the caudal hypothalamus 1.5 mm from the midline dorsal to the mammillary bodies. Phenoxybenzamine, prazosin and yohimbine solutions were infused intracerebroventricularly at a rate of 20 microliters min-1. Phenoxybenzamine did not cause any effects additional to those attributable to the solvent alone. Prazosin attenuated the evoked bradycardia at all doses (40 to 300 micrograms) and altered resting heart rate (HR) and arterial blood pressure (BP) after the higher doses. Yohimbine (200 + 300 micrograms) attenuated the bradycardia with negligible effects on HR and BP. Prazosin and yohimbine were given intravenously. Both caused dose-related attenuation of evoked bradycardia but prazosin also lowered BP sufficiently for this action alone to account for almost all the loss of bradycardia. The weaker hypotensive action of yohimbine was insufficient to account for the attenuation, a conclusion confirmed in animals whose BP was maintained constant by noradrenaline infusion after cervical spinal transection. In this preparation yohimbine caused dose-related attenuation of the bradycardia. The experiments have shown that yohimbine and probably prazosin also, can prevent hypothalamic stimulation from evoking bradycardia. The results suggest the presence of an alpha-adrenergic pathway from this region of the hypothalamus which projects caudally to increase the gain of the cardio-decelerator baroreceptor reflex in the rabbit.
用氯醛糖 - 乌拉坦麻醉的家兔,通过对距乳头体背侧中线1.5毫米的下丘脑尾部选定部位进行电刺激(200或300微安,1毫秒,60次/秒,持续9秒,每5分钟重复一次)诱发心动过缓。将酚苄明、哌唑嗪和育亨宾溶液以20微升/分钟的速率脑室内注入。酚苄明除了单独溶剂所产生的作用外未引起任何其他效应。哌唑嗪在所有剂量(40至300微克)下均减弱诱发的心动过缓,且较高剂量后改变静息心率(HR)和动脉血压(BP)。育亨宾(200 + 300微克)减弱心动过缓,对HR和BP的影响可忽略不计。哌唑嗪和育亨宾静脉给药。两者均引起诱发心动过缓的剂量相关减弱,但哌唑嗪也充分降低BP,仅这一作用就几乎可解释心动过缓的全部消失。育亨宾较弱的降压作用不足以解释这种减弱,这一结论在颈髓横断后通过去甲肾上腺素输注维持BP恒定的动物中得到证实。在该制备中,育亨宾引起心动过缓的剂量相关减弱。实验表明,育亨宾以及可能还有哌唑嗪,可防止下丘脑刺激诱发心动过缓。结果提示存在一条从下丘脑该区域发出的α - 肾上腺素能通路,其向尾侧投射以增加家兔心减速压力感受器反射的增益。